Extramedullary plasmacytoma with a t(11;14)(q13;q32) and aggressive clinical course

被引：2
|
作者：
Parkins, Elizabeth [2 ]
Boll, Maayke [1 ]
O'Connor, Sheila J. M. [1 ]
Rawstron, Andy C. [1 ]
Owen, Roger G. [1 ]
机构：
[1] Leeds Teaching Hosp NHS Trust, HMDS Lab, Leeds, W Yorkshire, England
[2] Royal Cornwall Hosp NHS Trust, Truro, England
来源：
LEUKEMIA & LYMPHOMA | 2010年 / 51卷 / 07期
关键词：
MULTIPLE-MYELOMA; NETWORK;
D O I：
10.3109/10428194.2010.486454
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1360 / 1362
页数：3
相关论文
共 50 条
  • [21] Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas
    Siebert, R
    Matthiesen, P
    Harder, S
    Zhang, Y
    Borowski, A
    Zuhlke-Jenisch, R
    Plendl, H
    Metzke, S
    Joos, S
    Zucca, E
    Weber-Matthiesen, K
    Roggero, E
    Grote, W
    Schlegelberger, B
    ANNALS OF ONCOLOGY, 1998, 9 (05) : 519 - 526
  • [22] 13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): A cytogenetic and interphase cytogenetic study
    Bigoni, R
    Cuneo, A
    Roberti, MG
    Bardi, A
    Rigolin, GM
    Campioni, D
    Pedriali, L
    Piva, N
    Bullrich, F
    Croce, C
    Castoldi, GL
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 144 - 144
  • [23] High incidence of translocations t(11;14) (q13;q32) and t(4;14) (p16;q32) in patients with plasma cell malignancies.
    Avet-Loiseau, H
    Li, JY
    Facon, T
    Brigaudeau, C
    Morineau, N
    Maloisel, F
    Rapp, MJ
    Talmant, P
    Trimoreau, F
    Jaccard, A
    Harousseau, JL
    Bataille, R
    BLOOD, 1998, 92 (10) : 716A - 717A
  • [24] The (11;14)(q13;q32) translocation in multiple myeloma - A morphologic and immunohistochemical study
    Hoyer, JD
    Hanson, CA
    Fonseca, R
    Greipp, PR
    Dewald, GW
    Kurtin, PJ
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2000, 113 (06) : 831 - 837
  • [25] Large variation in t(11;14)(q13;q32) and t(14;18)(q32;q21) translocation product size is confirmed by sequence analysis of PCR products
    Wickham, C. L.
    Harries, L. W.
    Sarsfield, P.
    Joyner, M. V.
    Ellard, S.
    CLINICAL AND LABORATORY HAEMATOLOGY, 2006, 28 (04): : 248 - 253
  • [26] TRANSLOCATION (12 14)(Q13 Q32) IN MYELODYSPLASTIC SYNDROME
    BADIA, L
    ALVAREZ, MA
    PALAU, F
    PRIETO, F
    CANCER GENETICS AND CYTOGENETICS, 1993, 65 (01) : 76 - 78
  • [27] Acquisition of a t(11;14)(q13;q32) in clonal evolution in a follicular lymphoma with a t(14;18)(q32;q21) and t(3;22)(q27;q11.2)
    Koduru, Prasad R.
    Chen, Weina
    Garcia, Rolando
    Fuda, Franklin
    CANCER GENETICS, 2015, 208 (06) : 303 - 309
  • [28] Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and-17p13 in myeloma patients treated with high-dose therapy
    Gertz, MA
    Lacy, MQ
    Dispenzieri, A
    Greipp, PR
    Litzow, MR
    Henderson, KJ
    Van Wier, SA
    Ahmann, GJ
    Fonseca, R
    BLOOD, 2005, 106 (08) : 2837 - 2840
  • [29] Favorable survival of multiple myeloma patients with t(11;14)(q13;q32) plus normal chromosome 13q.
    Kaufmann, H
    Baldia, C
    Ackermann, J
    Noesslinger, T
    Gisslinger, H
    Jaeger, U
    Sagaster, V
    Seidl, S
    Keck, A
    Ludwig, H
    Simonitsch-Klupp, I
    Zielinski, C
    Drach, J
    BLOOD, 2004, 104 (11) : 942A - 942A
  • [30] Correlation Between Losses of IGH or Its Segments and Deletions of 13q14 in t(11;14)(q13;q32) Multiple Myeloma
    Trakhtenbrot, Luba
    Hardan, Izhar
    Koren-Michowitz, Maya
    Oren, Shirley
    Yshoev, Galina
    Rechavi, Gideon
    Nagler, Arnon
    Amariglio, Ninette
    GENES CHROMOSOMES & CANCER, 2010, 49 (01): : 17 - 27
12345